4//SEC Filing
Kerr Douglas 4
Accession 0001415889-24-001334
CIK 0001733294other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 5:00 PM ET
Size
14.2 KB
Accession
0001415889-24-001334
Insider Transaction Report
Form 4
Kerr Douglas
CHIEF MEDICAL OFFICER
Transactions
- Tax Payment
Common Stock
2024-01-15$1.91/sh−2,320$4,431→ 382,083 total - Tax Payment
Common Stock
2024-01-15$1.91/sh−2,577$4,922→ 377,709 total - Exercise/Conversion
Restricted Stock Units
2024-01-15−7,437→ 7,437 total→ Common Stock (7,437 underlying) - Exercise/Conversion
Restricted Stock Units
2024-01-15−6,694→ 20,081 total→ Common Stock (6,694 underlying) - Exercise/Conversion
Common Stock
2024-01-15+6,694→ 384,403 total - Exercise/Conversion
Common Stock
2024-01-15+7,437→ 380,286 total
Footnotes (4)
- [F1]Each restricted stock unit represents the right to receive one share of the company's common stock.
- [F2]Includes 2,445 shares acquired under the company's employee stock purchase plan since October 17, 2023.
- [F3]On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter.
- [F4]On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
Documents
Issuer
Generation Bio Co.
CIK 0001733294
Entity typeother
Related Parties
1- filerCIK 0001814189
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 5:00 PM ET
- Size
- 14.2 KB